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and showed to be associated with toxicity. It is important to 
remember that such features, to some extent, might be 
confounded by more simple factors (e.g. tumor volume or 
volume of irradiated region). Nevertheless, image based 
features appears in a number of studies to add independent 
toxicity information; but it is likely that no single image-
based feature (or no single feature at all) will be able to 
make a perfect patient specific toxicity prediction for the 
entire population. In many studies the correlation between a 
specific image-based feature and observed toxicity is relative 
weak. However, if predictive toxicity models simply are able 
to identify a subset of patients who are likely to have modest 
toxicity that would be very beneficial, since this group of 
patients could then be offered a more aggressive treatment, 
which hopeful would result in improved local control. 
Predictive toxicity models should thus not only be evaluated 
on their overall prediction performance for the entire 
population, but also on their ability to identify a significant 
subgroup of patients who are candidates for intensified 
treatment.  
The current lecture will present examples of image-based 
features and point to their potential clinical impact; but will 
also focus on the potential use of patient specific toxicity 
models to select subgroups of patients as described above. 
Moreover comments on image quality will be made, since 
high images quality is the foundation for imaged-based 
features used in predictive models for toxicity. 
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In the field of toxicity modeling it is common practice to 
build statistical models starting from analysis of clinical data 
which are prospectively collected in the frame of 
observational trials. Modern prospective observational studies 
devoted to modelling of radioinduced toxicity are often 
accumulating a large amount of dosimetric and patient-
related information, this requires particular attention when 
normal tissue complication probability modelling is 
approached. A core issues is related to selection of features, 
which then influences overfitting, discrimination, 
personalization and generalizability.  
These risks are particularly high in clinical research datasets, 
which are often characterized by low cardinality - i.e. the 
number of cases is overall low - and are often strongly 
imbalanced in the endpoint categories – i.e. the number of 
positive cases (e.g. toxicity events or loss of disease control) 
is small, or even very small, with respect to the negative 
ones. This is obviously positive for patients, it is however a 
disadvantage for model building.  
In this context a possible methods using in-silico experiment 
approach for toxicity modelling will be discussed together 
with some applications.  
This method aimed at identifying the best predictors of a 
binary endpoint, with the purpose of detecting the leading 
robust variables and minimizing the noise due to the 
particular dataset, thus trying to avoid both under- and over-
fitting. It followed, with adjustments, a procedure firstly 
introduced by El Naqa [IJROBP2006]: the treatment response 
curve was approximated by the logistic function, while the 
bootstrap resamplings were performed to explore the 
recurrence of the selected variables in order to check their 
stability. A further bootstrap resampling was introduced for 
the evaluation of the odds ratios of the selected variables.  
The in-silico experiment was implemented using the KNIME 
software (KNIME GmbH, Germany) and consisted in the 
following processing steps:  
1) 1000 bootstrap samplings of the original dataset are 
created, as suggested by El Naqa [IJROBP2006];  
2) backward feature selection based on minimization of 
residuals is performed on each bootstrap sample;  
3) the rate of occurrences and the placement of each 
variable (selected by the backward feature selection) in the 
1000 bootstrapped datasets are used to classify the most 
robust predictors. A synthetic index, called normalized area, 
is defined for ranking each predictor: it corresponds to the 
area under the histogram representing the number of 
occurrences of each variable (x-axis) at a given importance 
level in each re-sampled dataset;  
4) a basket analysis of the 1000 sets of predictors is used to 
identify the predictors that appears together with higher 
probability;  
5) the best set of predictors is chosen, with its maximum size 
determined by the rule of thumb “one tenth of the number 
of toxicity events”; 
6) the distribution of odds ratios are determined through 
1000 bootstrap re-samplings of the original dataset including 
the set of predictors selected in the previous step;  
7) a logistic model with the best set of predictors and the 
median odds ratios, calculated from the distributions 
obtained in the previous step, is defined. 
In this approach, logistic regression is enhanced with 
upstream and downstream data processing to find stable 
predictors.  
The method was tested with satisfactory results on different 
datasets aimed at modelling radio-induced toxicity after 
high-dose prostate cancer radiotherapy. 
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Intensity modulated radiotherapy and volumetric modulated 
radiotherapy (VMAT) involves multiple manual steps, which 
might influence the plan quality and consistency, for example 
planning objectives and constraints need to be manually 
adapted to the patients individual anatomy, tumor location, 
size and shape [1]. Additional help structures are frequently 
defined on an individual basis to further optimize the 
treatment plan, resulting in an iterative process. This manual 
method of optimization is time consuming and the plan 
quality is strongly dependent on planner experience. This is 
especially true for complex cases such as head and neck (HN) 
carcinoma and stereotactic treatment. 
In order to improve the overall plan quality and consistency, 
and to decrease the time required for planning, automated 
planning algorithms have been developed [2,3]. In this pilot 
study, we compared two commercially available automatic 
planning systems for HN cancer patients. A VMAT model was 
created with a knowledge based treatment system, Auto-
Planning V9.10 (Pinnacle, Philips Radiation Oncology Systems, 
Fitchburg, WI) [4] and for a model based optimization 
system, RapidPlan V13.6 (Eclipse, Varian Medical System, 
Palo Alto, CA) [2]. These two models were used to optimize 
ten HN plans. Since the aim was to achieve plans of 
comparable quality to the manually optimized plans in a 
shorter time, only a single cycle of plan optimization was 
done for both automated treatment planning systems (TPS). 
Auto-Planning was additionally used to evaluate the 
treatment of lung and brain metastases stereotactic 
treatments.  
The results from the planning comparison for HN cancer 
patients showed a better target coverage with AutoPlanning 
in comparison to Rapidplan and manually optimized plans (p 
< 0.05). RapidPlan achieved better dose conformity in 
comparison to AutoPlanning (p < 0.05). No significant 
differences were observed for the OARs, except for the 
swallowing muscles where RapidPlan and the manually 
optimized plans were better than AutoPlanning and for the 
mandibular bones were AutoPlanning performed better than 
the two other systems. The working time needed to generate 
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clinical accepted plans for both automated TPS was 
drastically reduced to less than ten minutes.  
For the two stereotactic sites evaluated, target coverage and 
OARs doses differences were not clinically relevant between 
Auto-Planning and manually optimized plans.  
The encouraging results of automatic planning shows that 
highly consistent treatment plans for complex cases can be 
achieved with an automated planning process. 
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A knowledge based planning process, named RapidPlan, has 
been recently implemented into the Varian Eclipse treatment 
planning system. The goal of the engine is to generate 
patient tailored and personalized objectives to input in the 
optimization process for IMRT or VMAT inverse planning. Data 
from previously generated high quality plans are used to 
estimate DVH ranges where the specific DVH of a structure 
will most likely land according to the prior plans knowledge. 
Estimate-based optimisation objectives are hence generated. 
A complete pre-clinical preparation have been established 
before the clinical implementation of RapidPlan and the 
configured specific models. The anatomical sites and 
pathologies chosen for the first models generation in Milan 
were Head and Neck, and Breast. For the first site the choice 
was driven by the complexity of the planning phase due to 
the anatomy and critical structures; the breast was chosen 
since, beside of its planning complexity, almost one third of 
our patient population presents breast cancer. For each of 
the two chosen sites the process of the model generation 
included different phases. Initially a set of about 100 patients 
per site, having quite spread anatomical characteristics (as, 
for example, the breast size) while excluding extreme 
anatomies, was selected. The selected plans were all clinical 
plans of high quality, for VMAT (RapidArc) delivery. Those 
plans were used to train the model for the extraction of the 
parameters, based on prinicipal component analysis methods 
and regression models, needed to estimate the DVH for any 
new patient. The training results were analysed to evaluate 
possible outliers and their eventual exclusion from the 
model. Finally the validation process was followed on another 
group of patients to assess the model reliability and usability. 
From this last phase improvements in the plan quality when 
using RapidPlan was assessed. Once the two models were 
evaluated, a number of head and neck and breast cases were 
selected for the pre-clinical trial. The planners used to plan 
without RapidPlan were asked to produce plans using the 
knowledge based planning models. Two kind of evaluations 
were felt interesting: on one side the plan quality, for which 
the same cases were asked to be planned without RapidPlan 
by the same planner, and on the other side the time required 
to obtain such plans. The results were very promising, both 
on the plan quality, and especially on planning time. We are 
ready to move to the clinical daily use of the automated 
treatment plan generation. 
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Aim: Treatment plan generation in radiotherapy is commonly 
a trial-and-error procedure in which a dosimetrist tries to 
steer the treatment planning system (TPS) towards an 
acceptable patient dose distribution. For a single patient, 
this process may take up to several days of workload. The 
quality of the final treatment plan is dependent on the skills 
and experience of the dosimetrist, and on allotted time. In 
addition, for the treating physician it is extremely difficult to 
assess whether the generated plan is indeed optimal 
considering the unique anatomy of the individual patient. At 
Erasmus MC, systems for fully automated plan generation 
have been developed to obtain plans of consistent high 
quality, with a minimum of workload. This presentation will 
focus on their clinical implementation and applications.  
 
Materials and methods: An IMRT or VMAT plan is generated 
fully automatically (i.e., without human interface) by the 
clinical TPS (Monaco, Elekta AB), based on a patient-specific 
template. The patient-specific template is automatically 
extracted from a plan generated with Erasmus-iCycle, our in-
house developed pre-optimizer for lexicographic multi-
criterial plan generation (Med Phys. 2012; 39: 951-963). For 
individual patients of a treatment site (e.g., prostate), 
automatic plan generation in Erasmus-iCycle is based on a 
fixed ‘wishlist’ with hard constraints and treatment 
objectives with assigned priorities. The higher the priority of 
an objective, the higher the chance that the planning aim 
will be achieved, or even superseded. All plans generated 
with Erasmus-iCycle are Pareto optimal. In case of IMRT, the 
system can be used for integrated beam profile optimization 
and (non-coplanar) beam angle selection. Site-specific 
wishlists are a priori generated in an iterative procedure 
with updates of the wishlist in every iteration step, based on 
physicians’ feedback on the quality of plans generated with 
the current wishlist version. Also for patients treated at a 
Cyberknife, either with the variable aperture collimator (Iris) 
or MLC, the clinical TPS (Multiplan, Accuray Inc.) can be used 
to automatically generate a deliverable plan, based on a pre-
optimization with Erasmus-iCycle. 
 
Results: Currently, automatic treatment planning is clinically 
used for more than 30% of patients that are treated in our 
department with curative intent. It is routinely applied for 
prostate, head and neck, lung and cervical cancer patients 
treated at a linac. In a prospective clinical study for head and 
neck cancer patients, treating radiation oncologists selected 
the Erasmus-iCycle/Monaco plan in 97% of cases rather than 
the plan generated with Monaco by trial-and-error (IJROBP 
2013; 85: 866-72). For a group of 41 lung cancer patients, 
clinically acceptable VMAT plans could be generated fully 
automatically in 85% of cases; in all those cases plan quality 
was superior compared to manually generated Monaco plans, 
due to a better PTV coverage, dose conformality, and/or 
sparing of lungs, heart and oesophagus. For plans that were 
initially not clinically acceptable, it took a dosimetrist little 
hands-on time (<10 minutes) to modify them to a clinically 
acceptable plan. In 44 dual-arc VMAT Erasmus-iCycle/Monaco 
plans for cervical cancer treatment small bowel V45Gy was 
reduced by on average 20% (p<0.001) when compared to the 
plans that were manually generated by an expert Monaco 
user, spending 3 hours on average. Differences in bladder, 
rectal and sigmoid doses were insignificant. For 30 prostate 
cancer patients, differences between Erasmus-iCycle/Monaco 
VMAT plans and VMAT plans manually generated by an expert 
planner with up to 4 hours planning hands-on time, were 
statistically insignificant (IJROBP 2014; 88(5): 1175-9). 
Attempts to use acceptable, automatically generated plans 
as a starting point for manual generation of further improved 
plans have been unsuccessful. For prostate SBRT, clinically 
deliverable Cyberknife plans that were automatically 
generated with Erasmus-iCycle/Multiplan showed a better 
rectum sparing and a reduced low-medium dose bath 
compared to automatically generated VMAT plans with the 
same CTV-PTV margin.  
 
Conclusion: In our department, automatic plan generation 
based on Erasmus-iCycle is currently widely used, showing a 
consistent high plan quality and a vast reduction in planning 
workload. Extension to new target sites (breast, liver, 
lymphoma, spine, vestibular schwannoma) is being 
investigated. In addition, the use of automated planning for 
intensity modulated proton therapy is being explored, making 
objective plan comparison with other modalities possible. 
